Evidence map›Paper›PMID 34182965›Full record

ArticleBMC public health2021

"Inequalities in access to medicines for diabetes and hypertension across the capitals in different regions of Brazil: a population-based study".

Vanessa Iribarrem Avena Miranda, Antônio Augusto Schäfer, Cristiane Damiani Tomasi, Jacks Soratto, Fernanda de Oliveira Meller, Marysabel Pinto Telis Silveira

Abstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Temporal trend in venous thromboembolism hospitalization rates in Brazil.Revista da Associacao Medica Brasileira (1992) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vanessa Iribarrem Avena MirandaPostgraduate Program in Public Health, University of Southern Santa Catarina, Av. Universitária, 1105, Criciúma, Santa Catarina, CEP: 88806-000, Brazil. vanessairi@unesc.net.ORCID 0000-0002-9156-5036
Antônio Augusto SchäferPostgraduate Program in Public Health, University of Southern Santa Catarina, Av. Universitária, 1105, Criciúma, Santa Catarina, CEP: 88806-000, Brazil.ORCID 0000-0002-8834-0434
Cristiane Damiani TomasiPostgraduate Program in Public Health, University of Southern Santa Catarina, Av. Universitária, 1105, Criciúma, Santa Catarina, CEP: 88806-000, Brazil.ORCID 0000-0002-1813-765X
Jacks SorattoPostgraduate Program in Public Health, University of Southern Santa Catarina, Criciúma, Santa Catarina, Brazil.ORCID 0000-0002-1339-7268
Fernanda de Oliveira MellerPostgraduate Program in Public Health, University of Southern Santa Catarina, Av. Universitária, 1105, Criciúma, Santa Catarina, CEP: 88806-000, Brazil.ORCID 0000-0002-1174-4721
Marysabel Pinto Telis SilveiraPostgraduate Program in Epidemiology, University Federal of Pelotas, Pelotas, Rio Grande do Sul, Brazil.ORCID 0000-0002-6453-8534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo guarantee prevention and adequate treatment, as required for the population to have access to health services and technologies, including medicines. The purpose of this study is to analyse the economic and regional inequalities in access to medicines for diabetes and hypertension among the adult population in Brazil.

methodsThis was a cross-sectional study with adults aged 18 and over from the VIGITEL study conducted in 2019 in all Brazilian regions. Non-access to antidiabetic and antihypertensive drugs was assessed according to formal education and housing macro-region. The slope index of inequality (SII) was used to analyse absolute inequalities.

resultsThe total number of individuals interviewed was 52,443. Approximately 10.0% of the people with diabetes and/or hypertension reported not having access to drug treatment. The major means for having access to antihypertensive drugs, in all regions, was private pharmacies; for antidiabetics, in the North region, people had greater access through private pharmacies, while in the Northeast, Southeast and South, they had greater access through the public sector. Inequalities were found in the lack of access to medicines according to the region of residence, especially in the North region.

conclusionThe lack of access to medicines showed regional disparities, particularly in the most economically vulnerable regions.

Indexed as

Diabetes MellitusHypertensionAdolescentAdultBrazilCross-Sectional StudiesHealth Services AccessibilityHumansSocioeconomic FactorsCross-sectional studiesDiabetesHealth inequalitiesHypertensionPharmaceutical servicesPharmacoepidemiology

Identifiers

PMID34182965
PMCPMC8240304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.